Company sells 211,528 common shares, three-year warrants in offering
By Devika Patel
Knoxville, Tenn., Jan. 22 – Aldeyra Therapeutics, Inc. clarified details about a $2 million private placement of stock that settled on Jan. 20 in an 8-K filed Thursday with the Securities and Exchange Commission. This sale was reported as a $1.97 million placement in the Jan. 20 edition of Prospect News.
The company sold 211,528 common shares at $9.33 per share. The purchase price is an 8.26% discount to the Jan. 16 closing share price of $10.17 and is also the closing consolidated bid price per share of the stock on Jan. 16, according to the filing.
Investors also received warrants for 211,528 shares, which were purchased at $0.125 apiece. The warrants are each exercisable at $9.50 for three years. The strike price is a 6.59% discount to the Jan. 16 closing share price.
The biotechnology company is based in Burlington, Mass.
| Issuer: | Aldeyra Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $2 million
|
| Shares: | 211,528
|
| Price: | $9.33
|
| Warrants: | For 211,528 shares
|
| Warrant price: | $0.125
|
| Warrant expiration: | Three years
|
| Warrant strike price: | $9.50
|
| Settlement date: | Jan. 20
|
| Stock symbol: | Nasdaq: ALDX
|
| Stock price: | $10.17 at close Jan. 16
|
| Market capitalization: | $69.32 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
